Global Slide Stainer Market Size study & Forecast, by Product (Reagents, Equipment and Consumables & Accessories), by Technology (Hematoxylin and Eosin, Immunohistochemistry, Cytology, Microbiology, Special Stains and Others), by Application (Disease Diag

Global Slide Stainer Market Size study & Forecast, by Product (Reagents, Equipment and Consumables & Accessories), by Technology (Hematoxylin and Eosin, Immunohistochemistry, Cytology, Microbiology, Special Stains and Others), by Application (Disease Diagnosis, Medical Research), by End-User (Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Other End-Users) and Regional Analysis, 2022-2029

Global Slide Stainer Market is valued at approximately USD 4.04 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.2% over the forecast period 2022-2029. Slide Stainer is a substance used in imparting of cells and tissues, it helps in microscopic identification and makes cellular study easy. The Slide Stainer market is expanding because of factors such as rising prevalence of cancer, increasing healthcare expenditure as well as growing geriatric population.

According to the International Agency for Research on Cancer (IARC), Globally, there were 17.0 million new instances of cancer and 9.5 million cancer-related deaths in 2018, and it is estimated to reach 27.5 million by million by year 2040. Another important component driving space increase is technological advancements and rising clinical trial activities. Biocare Medical LLC launched seven brand-new IVD IHC antibody markers on February 13, 2020, for use in clinical diagnostics and research. The most recent launch is concentrated on various immuno-oncology indicators, which are vital for advancing the development of early-stage cancer drugs and patient care. The successful launch of this product may provide patients with an alternative option. However, the high cost of Slide Stainer stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Slide Stainer Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to the rising geriatric population, rising adoption of advanced healthcare infrastructure and high prevalence of chronic disease and infections in the region. Furthermore, Asia Pacific is projected to grow at a fastest rate, owing to prevelance of lifestyle disease in the region

Major market players included in this report are:
F. hoffmann-la roche ltd.
Danaher
PHC Holdings Corporation
Merck KGAA
Agilent Technologies Inc
ABCAM PLC
Becton, Dickinson and Company
Siemens Healthineers AG
Sakura Finetek Japan Co. Ltd
Biocare Medical LLC

Recent Developments in the Market:
 In March 2022, Leica Biosystems announced the launch of new advanced staining solution named BOND-PRIME staining platform, the product offers quality, speedy as well as diagnostic productivity.
 In August 2021, The US-based Danaher Corporation announced the acquisition of Aldevron, LLC (Fargo, US). This acquisition would expand Danaher's selection of premium plasmid DNA, mRNA, and proteins that it offers to the biotechnology and pharmaceutical industries for use in research, clinical, and commercial settings.

Global Slide Stainer Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Technology, Application, End-user, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:
By Product:
Reagents
Equipment
Consumables & Accessories
By Technology:
Hematoxylin and Eosin
Immunohistochemistry
Cytology
Microbiology
Special Stains
Others
By Application:
Disease Diagnosis
Medical Research
By End-Use:
Hospitals & Diagnostic Laboratories
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Other End Users

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Companies Mentioned

F. hoffmann-la roche ltd.
Danaher
PHC Holdings Corporation
Merck KGAA
Agilent Technologies Inc
ABCAM PLC
Becton, Dickinson and Company
Siemens Healthineers AG
Sakura Finetek Japan Co. Ltd
Biocare Medical LLC

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.